An open label phase II trial of glufosfamide: A β-D-glucose-linked isophosphoramide mustard given as 1-hour infusion in patients with advanced breast cancer This is an ASCO Meeting Abstract from the ...
Tamoxifen's agonist effect on breast cancer growth is mediated by activation of EGFR/HER-2 with preservation of its antagonist effect on ER-dependent gene expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback